https://www.biospace.com/employer/2151504/lyell-immunopharma-inc Lyell Immunopharma, Inc. en-US Thu, 11 Feb 2021 16:27:18 GMT https://www.biospace.com/biospace-movers-and-shakers-feb-12 Alex Keown Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. Thu, 11 Feb 2021 16:27:18 GMT https://www.biospace.com/biospace-movers-and-shakers-feb-12 https://www.biospace.com/lyell-completes-cutting-edge-65-million-cell-therapy-facility Brandon May Lyell Immunopharma announced this week that it has completed construction of a $65 million, 70,000-square-foot LyFE Manufacturing Center, which the company will use to support clinical trials and meet cell therapy manufacturing needs. Thu, 25 Mar 2021 12:25:56 GMT https://www.biospace.com/lyell-completes-cutting-edge-65-million-cell-therapy-facility https://www.biospace.com/a-busy-few-weeks-of-biotech-ipos Mark Terry The last few weeks have seen a flurry of filings for initial public offerings by biotech companies. Here’s a look. Wed, 09 Jun 2021 14:47:52 GMT https://www.biospace.com/a-busy-few-weeks-of-biotech-ipos https://www.biospace.com/biotech-dominates-the-nasdaq-this-week Kate Goodwin Biotech companies are dominating Nasdaq’s IPO scheduled this week. Here’s who is making their big public debut. Thu, 17 Jun 2021 12:44:29 GMT https://www.biospace.com/biotech-dominates-the-nasdaq-this-week https://www.biospace.com/money-on-the-move-june-16-22 Kate Goodwin Life sciences advances continue to be an exciting opportunity for investors. Here's a glance at the companies attracting fresh funding the past week. Wed, 23 Jun 2021 13:10:36 GMT https://www.biospace.com/money-on-the-move-june-16-22 https://www.biospace.com/clinical-catch-up-december-11-17 Mark Terry It was an enormously busy week with plenty of announcements from the American Society of Hematology meeting and numerous companies working to get the news out ahead of the holidays and year-end. Here’s a look. Fri, 17 Dec 2021 21:41:11 GMT https://www.biospace.com/clinical-catch-up-december-11-17 https://www.biospace.com/23andme-eqrx-lead-ipo-rush-in-2021 Alex Keown The year kicked off with a bang as multiple companies raced to a public listing. Mon, 20 Dec 2021 14:33:11 GMT https://www.biospace.com/23andme-eqrx-lead-ipo-rush-in-2021 https://www.biospace.com/tscan-therapeutics-lyell-sqz-and-more-receive-ind-clearance Alex Keown TScan Therapeutics, Lyell, SQZ Biotech and others secured clearance from the U.S. Food and Drug Administration for their Investigational New Drug Application. Mon, 24 Jan 2022 14:35:35 GMT https://www.biospace.com/tscan-therapeutics-lyell-sqz-and-more-receive-ind-clearance https://www.biospace.com/clinical-catch-up-january-24-january-28 Mark Terry Clinical trial news definitely picked up this final week of January. Here’s a look. Fri, 28 Jan 2022 16:07:44 GMT https://www.biospace.com/clinical-catch-up-january-24-january-28 https://www.biospace.com/biospace-movers-and-shakers-feb-4 Alex Keown Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers. Thu, 03 Feb 2022 19:26:01 GMT https://www.biospace.com/biospace-movers-and-shakers-feb-4